HOME > VC DEALS > Matchpoint Therapeutics
Deal IconDeal

Matchpoint Therapeutics

Matchpoint Therapeutics raises $150M Series B

Matchpoint Therapeutics, a Watertown, MA-based precision covalent therapeutics developer, raised $150 million in a Series B fundraising round led by Nextech Invest and Norwest with participation from Invus.

More on VC News Daily →


Similar Health deals

The VC Industry's trusted resource

Stay informed on industry shifts, deal trends, and career opportunities in venture capital.

Jobs